The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability

Journal of Experimental Medicine

Volumn 203, Issue 5, 2006, Pages 1319-1328

  Lazarski, Christopher A ^a,b,c   Chaves, Francisco A ^a,b   Sant, Andrea J ^a,b  

^a Rochester Inst of Biomed Sciences   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN DM; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD4 LYMPHOCYTE COUNT; IMMUNE RESPONSE; IMMUNOGENICITY; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA EDITING;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KINETICS; PEPTIDES; PROTEIN BINDING;

EID: 33646697124     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060058     Document Type: Article

References (51)

1. Mosyak, L., D.M. Zaller, and D.C. Wiley. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity. 9:377-383.
2. Fremont, D.H., F. Crawford, P. Marrack, W.A. Hendrickson, and J. Kappler. 1998. Crystal structure of mouse H2-M. Immunity. 9:385-393.
3. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 82:155-165.
4. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
5. Stebbins, C.C., M.E. Peterson, W.M. Suh, and A.J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892-4898.
6. Doebele, R.C., R. Busch, H.M. Scott, A. Pashine, and E.D. Mellins. 2000. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity. 13:517-527.
7. Stratikos, E., L. Mosyak, D.M. Zaller, and D.C. Wiley. 2002. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis. J. Exp. Med. 196:173-183.
8. Denzin, L.K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153-2165.
9. Kropshofer, H., G.J. Hammerling, and A.B. Vogt. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today. 18:77-82.
10. Sloan, V.S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D.M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 375:802-806.
11. Weber, D.A., B.D. Evavold, and P.E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science. 274:618-620.
12. k during antigen processing. J. Immunol. 171:2183-2186.
13. Kropshofer, H., A.B. Vogt, G. Moldenhauer, J. Hammer, J.S. Blum, and G.J. Hammerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144-6154.
14. Katz, J.F., C. Stebbins, E. Appella, and A.J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747-1753.
15. Lightstone, L., R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler. 1997. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA. 94:5772-5777.
16. d class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. Int. Immunol. 9:889-896.
17. k cells. J. Immunol. 157:2247-2255.
18. Kovats, S., P.E. Whiteley, P. Concannon, A.Y. Rudensky, and J.S. Blum. 1997. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur. J. Immunol. 27:1014-1021.
19. Pathak, S.S., J.D. Lich, and J.S. Blum. 2001. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM. J. Immunol. 167:632-635.
20. Raddrizzani, L., E. Bono, A.B. Vogt, H. Kropshofer, F. Gallazzi, T. Sturniolo, G.J. Hammerling, F. Sinigaglia, and J. Hammer. 1999. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM. Eur. J. Immunol. 29:660-668.
21. van Ham, S.M., U. Gruneberg, G. Malcherek, I. Broker, A. Melms, and J. Trowsdale. 1996. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184:2019-2024.
22. Belmares, M.P., R. Busch, K.W. Wucherpfennig, H.M. McConnell, and E.D. Mellins. 2002. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J. Immunol. 169:5109-5117.
23. Anderson, M.W., and J. Gorski. 2003. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability. J. Immunol. 171:5683-5687.
24. Stratikos, E., D.C. Wiley, and L.J. Stern. 2004. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain. J. Immunol. 172:1109-1117.
25. Nanda, N., and A.J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192:781-788.
26. Siklodi, B., A.B. Vogt, H. Kropshofer, F. Falcioni, M. Molina, D.R. Bolin, R. Campbell, G.J. Hammerling, and Z.A. Nagy. 1998. Binding affinity independent contribution of peptide length to the stability of peptide-HLA-DR complexes in live antigen presenting cells. Hum. Immunol. 59:463-471.
27. Chou, C.L., and S. Sadegh-Nasseri. 2000. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J. Exp. Med. 192:1697-1706.
28. Lazarski, C.A., F.A. Chaves, S.A. Jenks, S. Wu, K.A. Richards, J.M. Weaver, and A.J. Sant. 2005. The kinetic stability of MHC class II: peptide complexes is a key parameter that dictates immunodominance. Immunity. 23:29-40.
29. Nanda, N.K., and A.J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192:781-788.
30. d MHC class II molecules with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. J. Immunol. Methods. 300:74-92.
31. Martineau, P., J.G. Guillet, C. Leclerc, and M. Hofnung. 1992. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Gene. 118:151.
32. Mougneau, E., F. Altare, A.E. Wakil, S. Zheng, T. Coppola, Z.E. Wang, R. Waldmann, R.M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science. 268:563-566.
33. Reiner, S., Z. Wang, F. Hatam, P. Scott, and R.M. Locksley. 1993. Th1 and Th2 cell antigen receptors in experimental Leishmaniasis. Science. 259:1457-1460.
34. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity. 8:319-329. (published erratum appears in Immunity. 1998. 8:531)
35. McFarland, B.J., J.F. Katz, A.J. Sant, and C. Beeson. 2005. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. J. Mol. Biol. 350:170-183.
36. McFarland, B.J., J.F. Katz, C. Beeson, and A.J. Sant. 2001. Energetic asymmetry among hydrogen bonds in MHC class II:peptide complexes. Proc. Natl. Acad. Sci. USA. 98:9231-9236.
37. Belmares, M.P., R. Busch, E.D. Mellins, and H.M. McConnell. 2003. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM. Biochemistry. 42:838-847.
38. Zarutskie, J.A., R. Busch, Z. Zavala-Ruiz, M. Rushe, E.D. Mellins, and L.J. Stern. 2001. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl. Acad. Sci. USA. 98:12450-12455.
39. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
40. Blum, J.S., C. Ma, and S. Kovats. 1997. Antigen-presenting cells and the selection of immunodominant epitopes. Crit. Rev. Immunol. 17:411-417.
41. Sant, A.J., F.A. Chaves, S.A. Jenks, K.A. Richards, P. Menges, J.M. Weaver, and C.A. Lazarski. 2005. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207:261-278.
42. Trombetta, E.S., and I. Mellman. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975-1028.
43. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:782-787.
44. + T cell response. J. Exp. Med. 201:1555-1565.
45. Gett, A.V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-360.
46. + T cells is amplified by prolonged T cell antigen receptor triggering. J. Exp. Med. 196:793-803.
47. Bajenoff, M., O. Wurtz, and S. Guerder. 2002. Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J. Immunol. 168:1723-1729.
48. Ferenci, T., and U. Klotz. 1978. Affinity chromatographic isolation of the periplasmic maltose binding protein of Escherichia coli. FEBS Lett. 94:213-217.
49. Loss, G.E., Jr., C.G. Elias, P.E. Fields, R.K. Ribaudo, M. McKisic, and A.J. Sant. 1993. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J. Exp. Med. 178:73-85.
50. Scott, B., R. Liblau, S. Degermann, L.A. Marconi, L. Ogata, A.J. Caton, H.O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:73-83.
51. Katz, J.F., and A.J. Sant. 1994. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent. J. Immunol. 152:1629-1640.